The breast cancer test looks for changes, or mutations, in two genes.
At present, based on animal models where human breast cancer tumors are grown in animals, this test detects breast cancers with 100% specificity, high sensitivity, and good localization.
FORBES: Breast Exams: Mammography Is Not The Only Game In Town
Genomic Health sells a test for breast cancer patients that predicts which patients are likely to relapse after surgery and thus need chemotherapy.
The issue of gene patents is coming to the fore with the first diagnostic test for breast cancer genes coming on to the market.
You're doing everything you can to make sure you're not next -- doing breast exams, getting mammograms -- but you think it would be great if you could get a test to see if you'll develop breast cancer.
Some breast cancer patients already get a specialized gene test to help determine what treatment is right for them.
Myriad has used its patents to develop its BRACAnalysis test looks for mutations on the breast cancer predisposition gene, or BRCA. Those mutations are associated with much greater risks of breast and ovarian cancer.
Its breast cancer drug Herceptin was the first to pair a diagnostic test with a drug to determine which patients it could help.
In an unusual move, it plans to test Afinitor simultaneously on five other tumor types, including stomach, breast and neuroendocrine tumors (the type Apple's Steve Jobs has suffered from).
It could be that the research enables scientists to develop a test to identify women who would be better off receiving a different breast cancer drug, such as anastrozole.
Almost 80 breast cancer patients were recalled by King's Mill Hospital after being given inaccurate test results.
BBC: King's Mill Hospital patient feels 'let down' after error
The hospital said more than 20 breast cancer patients have been recalled for a treatment review after a series of hormone test inaccuracies.
Celldex enrolled 120 patients with advanced breast cancer that over-expresses a protein known as GPNMB (confirmed by an independent test).
Separately at the beginning of October, it emerged almost 80 breast cancer patients were being recalled by King's Mill Hospital after being given inaccurate test results.
BBC: Rat in theatre leads to 40 ops cancelled at King's Mill
There is indeed a test to see whether you have genes that make it likely you'll get breast cancer.
The new test would identify cells that over-expressed three genes Corixa discovered while trying to develop a breast cancer vaccine.
应用推荐